Skip to main content
Caplight Logo









Meduloc

Meduloc

Private
Del Mar, CaliforniaHealthcare & Life Scienceshttps://www.meduloc.com/

Last Round

Series B

Aug 6, 2026

Total Funding Raised

$8M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Meduloc is a medical device company that develops minimally invasive intramedullary fixation systems for small and long bone fractures.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

orthopedic implantsintramedullary fixationminimally invasive surgerynitinol implantsfracture fixationorthopedic hardwaresurgical implantsorthopedic devicesbone fixationmedical device manufacturerortho implantsMISimplantable medical devicessurgical instrumentation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Meduloc Comparables

Compare Meduloc with similar companies based on industry and business-model similarity.

Meduloc comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Fusion Orthopedics
83%
Extremity Medical, LLC
83%
RMR Ortho, Inc.
82%

Meduloc Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BAug 6, 2026
Series AFeb 6, 2026
SeedFeb 21, 2024

Key People

Founding team and executive leadership

Sarah Sachinis

Chief Executive Officer and President

Executive Team

Meduloc Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 6, 2026

    $4M round with participation from Benjamin Franklin Technology Partners and Broad Street Angels.

  • Feb 6, 2026

    $2.16M round raised

Recent news

Latest coverage and updates

  • receives_financingAug 6, 2026

    Meduloc received financing of $4M in Series B on Aug 6th '26.

Meduloc Filings

Explore SEC and related filing metadata, where available.

Meduloc filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Meduloc's valuation, stock price, and market status.

Is Meduloc a public or private company?

Meduloc is a private company.

What is the current stock price of Meduloc?

Meduloc is a private company with no public stock price. Caplight tracks Meduloc's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is Meduloc worth (valuation)?

Valuation information for Meduloc is not publicly available.

Can I buy Meduloc stock?

Meduloc shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Meduloc's last funding round?

Meduloc's most recent funding round was Series A on February 6, 2026.

Who are the main investors in Meduloc?

Investor information for Meduloc is not publicly disclosed.

Will Meduloc IPO soon?

No public IPO plans have been announced for Meduloc.

How can I track Meduloc secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Meduloc's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDel Mar, California
Employee Range2
Year Founded2016
Last FundingAug 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?